NMNAT-2 inhibitors belong to a distinct chemical class that plays a crucial role in modulating cellular processes. These inhibitors are characterized by their ability to interact specifically with the enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2), a critical component in the biosynthesis of nicotinamide adenine dinucleotide (NAD+). NAD+ is a coenzyme that participates in various metabolic reactions, including redox reactions, energy production, and DNA repair. NMNAT-2, as a key enzyme in the NAD+ salvage pathway, catalyzes the conversion of nicotinamide mononucleotide (NMN) to NAD+, thereby contributing to the maintenance of cellular NAD+ levels.NMNAT-2 inhibitors act by binding to the active site of the NMNAT-2 enzyme, disrupting its normal catalytic function. This leads to a downregulation of NAD+ biosynthesis, potentially impacting cellular processes that rely on NAD+-dependent enzymatic activities. These inhibitors are designed with a precise molecular architecture that enables them to form specific interactions with the active site residues of NMNAT-2, thereby inhibiting its enzymatic activity with high affinity.
Research into NMNAT-2 inhibitors is motivated by their potential to uncover novel insights into cellular pathways and to shed light on the intricate regulatory mechanisms underlying NAD+ metabolism. Understanding the effects of these inhibitors on cellular processes could contribute to advancing our knowledge of fundamental biological mechanisms. As researchers explore the properties and interactions of NMNAT-2 inhibitors, they aim to decipher the broader implications of NAD+ regulation. In conclusion, NMNAT-2 inhibitors constitute a distinctive chemical class that selectively targets the NMNAT-2 enzyme, a vital player in NAD+ biosynthesis. By interfering with NMNAT-2's catalytic activity, these inhibitors hold the potential to illuminate the intricate roles of NAD+ in cellular function and provide valuable insights into the broader landscape of biological regulation. Ongoing research in this field seeks to unravel the multifaceted implications of NMNAT-2 inhibition, contributing to a deeper understanding of cellular processes at the molecular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
FK-866 | 658084-64-1 | sc-205325 sc-205325A | 5 mg 10 mg | $143.00 $250.00 | 12 | |
This compound is known to inhibit NMNAT-2 by targeting the NAD+ biosynthesis pathway. | ||||||
3-Aminobenzamide | 3544-24-9 | sc-3501 sc-3501B sc-3501A | 100 mg 1 g 5 g | $15.00 $37.00 $52.00 | 18 | |
This compound has been suggested as an NMNAT-2 inhibitor in certain studies. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
While initially identified as a Wnt pathway inhibitor, XAV939 has also been investigated for its potential NMNAT-2 inhibitory effects. | ||||||